Devonian Health Group Inc.
DVHGF
$10.65
$6.38149.65%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.23M | 13.08M | 16.81M | 23.29M | 22.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.23M | 13.08M | 16.81M | 23.29M | 22.11M |
| Cost of Revenue | 4.00M | 8.04M | 10.70M | 14.85M | 14.42M |
| Gross Profit | 3.23M | 5.04M | 6.11M | 8.44M | 7.69M |
| SG&A Expenses | 6.38M | 4.85M | 5.15M | 6.11M | 5.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 93.40K | 91.50K | 90.90K | 89.60K | 89.60K |
| Total Operating Expenses | 10.36M | 14.38M | 17.37M | 22.49M | 21.50M |
| Operating Income | -3.13M | -1.30M | -568.80K | 795.20K | 606.70K |
| Income Before Tax | -6.44M | -4.64M | -3.96M | -2.71M | 395.80K |
| Income Tax Expenses | -9.20K | 298.30K | 298.30K | 728.10K | 928.10K |
| Earnings from Continuing Operations | -6.43 | -4.94 | -4.26 | -3.44 | -0.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.43M | -4.94M | -4.26M | -3.44M | -532.30K |
| EBIT | -3.13M | -1.30M | -568.80K | 795.20K | 606.70K |
| EBITDA | -2.98M | -1.12M | -352.50K | 1.04M | 866.50K |
| EPS Basic | -3.08 | -1.95 | -1.72 | -1.39 | -0.22 |
| Normalized Basic EPS | -1.07 | -0.28 | -0.14 | 0.18 | 0.10 |
| EPS Diluted | -3.08 | -1.95 | -1.72 | -1.39 | -0.22 |
| Normalized Diluted EPS | -1.07 | -0.28 | -0.14 | 0.18 | 0.11 |
| Average Basic Shares Outstanding | 13.23M | 10.17M | 9.88M | 9.88M | 9.87M |
| Average Diluted Shares Outstanding | 13.43M | 10.37M | 10.08M | 10.08M | 10.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |